Amygdala Neurosciences
Headquarters:
Palo Alto, CA
Deal Team:
Lou Lange
Biopharmaceutical company focused on developing and commercializing first-in-class therapy for substance use disorders.
AMV
AMV is a venture capital firm investing in
early-stage digital health, technology and
life sciences companies.
2595 E Bayshore Rd, Suite 240
Palo Alto, CA
650.621.8808
© 2019 Asset Management Ventures
All Rights Reserved
Headquarters:
Palo Alto, CA
Deal Team:
Lou Lange
Biopharmaceutical company focused on developing and commercializing first-in-class therapy for substance use disorders.
AMV
AMV is a venture capital firm investing in
early-stage digital health, technology and
life sciences companies.
2595 E Bayshore Rd, Suite 240
Palo Alto, CA
650.621.8808
© 2019 Asset Management Ventures
All Rights Reserved
Total raised: $18M
Investors 1
| Date | Name | Website |
| - | Asset Mana... | assetman.c... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 18.11.2019 | - | $5.6M | - |
| 19.09.2018 | - | $12.4M | - |
Mentions in press and media 1
| Date | Title | Description |
| 18.11.2019 | Amygdala Neurosciences Raises $5.6M in Financing | Amygdala Neurosciences, Inc., a San Francisco, CA-based company developing pharmacotherapies to address need associated with substance use disorder, raised $5.6m in funding. The company intends to use the funds to conduct Phase 2 clinical s... |